Meridian Energy Changes of Head and Neck Cancer Patients After Chemotherapy or Radiotherapy

Not Applicable

Recruiting

• Conditions: Head and Neck Cancer
• Interventions: Device: Meridian Electroacupuncture Analysis Device (MEAD)

• Registration Number: NCT04872517
• Lead Sponsor: Liao Jian An

Brief Summary

This trial is conducted by using MEAD to detect the meridian changes in patients with head and neck cancer after conventional treatment of chemotherapy or radiotherapy.

Detailed Description

The purpose of this research is observe the change of meridian energy in patients have be diagnosed with head and neck cancer. The instrument we use is a non-invasive device called meridian energy analysis device(MEAD). The theory of MEAD is use conductive rod to measure the skin resistance from the specific point in human body, and to calculate the meridian's energy change. In Traditional Chinese Medicine theory, physician doctor believe that the median in human body would be affected by disease or uncomfortable condition. So, this time, we who a group of physician of Traditional Chinese medicine department conduct this research to assess the energy change in patients with head and neck cancer. The trail cooperate with radiation oncology department and hematology oncology department. Subject enrollment from radiation oncology department and hematology Oncology department. All of subjects have be diagnosed with head and neck cancer, and will to receive conventional treatment, no matter chemotherapy or/and radiotherapy.

The major assessment of our research is meridian energy by MEAD before treatment, and six consecutive cycles. In addition to this, pain degree, oral mucositis condition, impact on life quality, and blood test, diagnosis imaging data will be collected.

According to G\*Power( 3.1.9.4 edition), we expected to recruit 34 subjects. All of Statistical Analysis will use SPSS, pair-t test is used to analyze continuous variable, categorical variable will be analyzed by Chi-Square Test. Multivariate regression analysis will be apply to discuss the major factor of the meridian changes.

MEAD is a kind of non-invasive device, hasn't had adverse effect until now. We will start emergency handling If accidents happened within measurement.

Study Timeline

• Study Start: 2021-04-01
• Study First Submitted: 2021-04-27
• Study First Submitted QC: 2021-05-03
• Study First Posted: 2021-05-04
• Status Verified: 2023-09
• Last Update Submitted: 2023-09-06
• Last Update Posted: 2023-09-07
• Primary Completion: 2023-12-31
• Study Completion: 2024-03-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

1. patients with head and neck cancer, included nasopharyngeal carcinoma, laryngeal cancer, oropharyngeal cancer, ear and oral cancer, hypopharyngeal cancer, salivary-gland carcinoma. Aged between 20 years old to 75years old, no gender difference.
2. patients with head and neck cancer has not received surgery yet, and will plan to accept chemotherapy and/or radiotherapy.
3. recurrent head and neck cancer, and expect to received chemotherapy and/or radiotherapy.
4. patient with vital sings stableness, conscious clear, and have ability to recognize the contain of trail and sign consent.
5. not accept other adjuvant therapy.
6. no brain metastasis or psychosis, and will to join whole course as well as accept assessments.

Exclusion Criteria

1. Aged less than 20 years old and over 75 years old。
2. Patients be diagnosed with head and neck cancer, and accepted surgery, or already finished chemotherapy and/or radiotherapy.
3. patient with brain metastasis, conscious unclear, and have not able to recognize the contain of trail and sign consent.
4. Accept other adjuvant therapy and chemotherapy and/or radiotherapy simultaneously.
5. Combined with serious organs failure。
6. Have contraindication in chemotherapy or radiotherapy.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
34 head and neck cancer patients, expected to proceed chemotherapy or radiotherapy in hospital.	Meridian Electroacupuncture Analysis Device (MEAD)	Total 34 anticipants will recruit in this research. Age was limited between 20years old to 75 years old. All of anticipants agree to join this trail and be followed through treatment , and without underlying disease that threaten life.

Primary Outcome Measures

Name	Time	Method
meridian energy	An average of 6 weeks	energy change in meridian

Secondary Outcome Measures

Name	Time	Method
pain degree	An average of 6 weeks	use Numerical Rating Scale(0-10) to assess.
adverse impact on quality of life	An average of 6 weeks	use EORTC QLQ - H\&N35 questionnaire to evaluate the treatment impact on subject feeling
Oral mucositis grading	An average of 6 weeks	compare enrollment subjects's oral condition with picture from MASCC/ISOO clinical practice guidelines (grade 0-grade 4)
the number of participants with blood test data abnormal	An average of 6 weeks	calculate the ratio of participants in hemodynamic alteration whom accept chemotherapy or/and radiotherapy, and compare the hemodynamic change with meridian energy change. Blood test include CBC/DC (WBC, RBC, Hemoglobin, Hematocrit, platelets, segment, lymphocyte, absolutely neutrophil), GOT/GPT, Bun/Creatinine, Bilirubin.
imaging diagnosis	An average of 6 weeks	compare tumor condition in diagnostic image data (shrink or progress) with the energy change in meridian.

Trial Locations

Locations (1)

Chang Cung Memorial Hospital; 🇨🇳 Keelung, Taiwan